ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (01541)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Fu Da Wei | 30-Jun-25 | MbNC | |||
| 28-May-25 | NED | ||||
| Gu Jiefeng | 01-Mar-16 | 29-Jul-24 | ChSup | ||
| 29-Jul-24 | Sup | In order to devote more time to his other business commitments | |||
| Guan Mei | 28-May-24 | ED | |||
| 14-Jun-22 | CoSec | ||||
| Kendall Arthur Smith | 30-Jun-25 | MbNC | |||
| Li Kin Wai | 14-Jun-22 | CoSec | |||
| Li Song | 17-Dec-15 | ED | |||
| Smith Kendall Arthur | 14-Jun-22 | INED | |||
| Song Zi Yi | 02-Mar-24 | CFO, AuRep | In order to devote more time to her other business commitments | ||
| Song Ziyi | 17-Jan-22 | 02-Mar-24 | FD, ED | In order to devote more time to her other business commitments | |
| Tian Miao | 24-Jul-17 | Sup | |||
| Tian Wenzhi | 18-Jun-15 | Ch, CEO, Fdr, ED | |||
| Xu Cong | 14-Oct-20 | NED | |||
| Yeung Rex Chi Tat | 14-Jun-22 | INED | |||
| Yu Xiaoyong | 15-Dec-15 | 30-Sep-24 | NED | In order to devote more time to his other business commitments. | |
| Yu Zhihua | 30-Mar-18 | 14-Oct-24 | NED | In order to devote more time to his other business commitments. | |
| Zhang Ru Liang | 28-May-25 | ED | |||
| Zhang Wei | 29-Jul-24 | Sup | |||
| Zhao Zimeng | 17-Jan-22 | Sup | |||
| Zhu Zhenping | 03-Aug-16 | 28-Aug-26 | INED | To devote more time to his other business commitments | |
| 28-Aug-26 | MbAC, MbCC, MbNC | To devote more time to his other business commitments |